According to the announcement from Zhongheng Group (600252.SH), the company's controlling subsidiary Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (referred to as "Wuzhou Pharmaceutical") participated in the national traditional Chinese medicine procurement alliance's centralized bulk procurement work. Recently, according to the announcement from the National Traditional Chinese Medicine Joint Procurement Office regarding the public notice of the proposed selected and non-quoted representative products for the centralized procurement of the national traditional Chinese medicine procurement alliance, Wuzhou Pharmaceutical's product, Thrombin Injection (Lyophilized), is proposed to be selected as a non-quoted representative product for this national traditional Chinese medicine procurement alliance's centralized bulk procurement, with the proposed selected product being Thrombin Injection (Lyophilized)